MedPath

Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS)

Phase 2
Conditions
Late-Onset Neonatal Sepsis
Pre-Term
Sepsis
Interventions
Biological: Olive Oil Massage
Registration Number
NCT04717037
Lead Sponsor
King Abdullah International Medical Research Center
Brief Summary

The OMEPS trial is a randomized clinical trial in the western region of Saudi Arabia. Conducted to assess the safety and feasibility of olive oil as massage for preterm infants and if associated with reduced risk of Late-Onset sepsis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Preterm infants born at one of the participated centers.
  2. Preterm Infants born at β‰₯24weeks gestation and ≀32weeks gestation
  3. Birth weight β‰₯ 500gm up to 2000 gm.
Exclusion Criteria
  1. Outborn Infants.
  2. Preterm infants < 24wk or > 32 wk
  3. Preterm infants < 500 gm or > 2000gm
  4. Critically ill patients, e.g., Hemodynamic unstable, culture-confirmed neonatal sepsis, Hydrops fetalis, Life-threatening congenital anomalies.
  5. Congenital skin anomalies or infection
  6. Major surgical procedure
  7. Any patient whose parents refuse consent.
  8. Death within 48 hours of life.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
StudyOlive Oil MassageThe olive oil massage will be applied initially at 72 hrs of life then twice daily with a dose of 4ml/kg till 28 days .
Primary Outcome Measures
NameTimeMethod
Rate of culture-proven sepsis in the blood or CSF72 hours from birth till 28 days of life

Primary outcomes defined as the rate of culture-proven sepsis in the blood or CSF in the 28 days of life.Late-onset sepsis defined as sepsis onset after 72 h of life.

The olive oil will be applied initially at 72 hours of life then twice daily with a dose of 4ml/kg.

Secondary Outcome Measures
NameTimeMethod
Neonatal Skin Condition score72 hours from birth till 28 days of life

Validated Scoring system \[ Neonatal Skin Condition Score \] will be used to score the skin integrity, and care will be monitored at baseline then weekly till age 28th of life or discharge.

Skin condition was assessed with the Neonatal Skin Condition Score,This score has 9 scores from 1 to 9, 1 depicting the best skin state and 9 the worst with erythema, blistering \& oozing over the entire area.

Trial Locations

Locations (2)

King Abdulaziz University Hospital

πŸ‡ΈπŸ‡¦

Jeddah, Saudi Arabia

King Abdulaziz Medical City

πŸ‡ΈπŸ‡¦

Jeddah, WR, Saudi Arabia

Β© Copyright 2025. All Rights Reserved by MedPath